Literature DB >> 20053445

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

D James Surmeier1, Jaime N Guzman, Javier Sanchez-Padilla.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease in developed countries. The core motor symptoms are attributable to the degeneration of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Why these neurons, and other restricted sets of non-dopamine neuron, succumb in PD is not clear. One potential clue has come from the observation that the engagement of L-type Ca2+ channels during autonomous pacemaking elevates the sensitivity of SNc DA neurons to mitochondrial toxins used to create animal models of PD, suggesting that Ca2+ entry is a factor in their selective vulnerability. Epidemiological data also supports a linkage between L-type Ca2+ channels and the risk of developing PD. This review examines the hypothesis that the primary factor driving neurodegenerative changes in PD is the metabolic stress created by sustained Ca2+ entry, particularly in the face of genetic or environmental factors that compromise oxidative defenses or proteostatic competence. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053445      PMCID: PMC3235732          DOI: 10.1016/j.ceca.2009.12.003

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  108 in total

1.  Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.

Authors:  D C German; K F Manaye; P K Sonsalla; B A Brooks
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

2.  Disease-specific patterns of locus coeruleus cell loss.

Authors:  D C German; K F Manaye; C L White; D J Woodward; D D McIntire; W K Smith; R N Kalaria; D M Mann
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

3.  Calbindin-D28k in the basal ganglia of patients with parkinsonism.

Authors:  H Ito; S Goto; S Sakamoto; A Hirano
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

4.  Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain.

Authors:  N W Soong; D R Hinton; G Cortopassi; N Arnheim
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

5.  Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

Authors:  T Yamada; P L McGeer; K G Baimbridge; E G McGeer
Journal:  Brain Res       Date:  1990-09-03       Impact factor: 3.252

Review 6.  Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  A Fitton; P Benfield
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

7.  Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease.

Authors:  C B Saper; D M Sorrentino; D C German; S de Lacalle
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

8.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

9.  Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones.

Authors:  S Nedergaard; J A Flatman; I Engberg
Journal:  J Physiol       Date:  1993-07       Impact factor: 5.182

10.  Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements.

Authors:  R Romo; W Schultz
Journal:  J Neurophysiol       Date:  1990-03       Impact factor: 2.714

View more
  77 in total

1.  Parkinson disease: calcium channel blockers and Parkinson disease.

Authors:  Ronald F Pfeiffer
Journal:  Nat Rev Neurol       Date:  2010-04       Impact factor: 42.937

Review 2.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.

Authors:  Gregor Zündorf; Georg Reiser
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

3.  Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.

Authors:  F Suárez; Q Zhao; D T Monaghan; D E Jane; S Jones; A J Gibb
Journal:  Eur J Neurosci       Date:  2010-07-06       Impact factor: 3.386

Review 4.  Ca(v)1.3 and BK channels for timing and regulating cell firing.

Authors:  David Henry Vandael; Andrea Marcantoni; Satyajit Mahapatra; Anton Caro; Peter Ruth; Annalisa Zuccotti; Marlies Knipper; Emilio Carbone
Journal:  Mol Neurobiol       Date:  2010-11-20       Impact factor: 5.590

Review 5.  Mitochondrial dynamics: the intersection of form and function.

Authors:  Andrew Ferree; Orian Shirihai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.

Authors:  Jaime N Guzman; Ema Ilijic; Ben Yang; Javier Sanchez-Padilla; David Wokosin; Dan Galtieri; Jyothisri Kondapalli; Paul T Schumacker; D James Surmeier
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

7.  Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Rafael Hortigüela; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Isabel Sastre; Alberto Rábano; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

8.  Calcium-activated non-selective cation currents are involved in generation of tonic and bursting activity in dopamine neurons of the substantia nigra pars compacta.

Authors:  Ana Mrejeru; Aguan Wei; Jan Marino Ramirez
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 9.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

10.  Selective neuronal vulnerability to oxidative stress in the brain.

Authors:  Xinkun Wang; Elias K Michaelis
Journal:  Front Aging Neurosci       Date:  2010-03-30       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.